Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Synthesis impurity
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Steroidogenesis inhibitor
H+/K+ ATPase inhibitor.
Sesquiterpene lactone derived from Artemesia; m...
Vitamin B, required for formation of NAD and NA...
Viral RNA polymerase inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Synthetic prednisolone prodrug; glucocorticoid ...
Endogenous pterin coenzyme required for release...
Alkaloid found in Catharanthus, precursor in sy...
Macrocyclic lactone.
Echinocandin antifungal
EGFR inhibitor.
TTK/CLK2 inhibitor.
Mycotoxin.
Purine (hypoxanthine) analog; xanthine oxidase ...
Derivative of aloe-emodin, anthraquinone found ...
Macrolide; ET antagonist, proteasome inhibitor....
HDAC inhibitor, mammalian RNA splicing modulato...